[LH-RH treatment of patients with prostatic cancer by subcutaneous injection, non-biodegradable and biodegradable slow delivery system and intranasal spray application].
D000281:Administration, Intranasal; D000368:Aged; D000369:Aged, 80 and over; D001673:Biodegradation, Environmental; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006728:Hormones / Q000008:administration & dosage*; D006801:Humans; D007279:Injections, Subcutaneous; D016729:Leuprolide; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D006728:Hormones; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide